NO313984B1 - Östradioltransdermalt terapeutisk system - Google Patents
Östradioltransdermalt terapeutisk system Download PDFInfo
- Publication number
- NO313984B1 NO313984B1 NO19970360A NO970360A NO313984B1 NO 313984 B1 NO313984 B1 NO 313984B1 NO 19970360 A NO19970360 A NO 19970360A NO 970360 A NO970360 A NO 970360A NO 313984 B1 NO313984 B1 NO 313984B1
- Authority
- NO
- Norway
- Prior art keywords
- estradiol
- matrix
- active substance
- therapeutic system
- transdermal
- Prior art date
Links
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title claims abstract description 32
- 229960005309 estradiol Drugs 0.000 title claims abstract description 30
- 229930182833 estradiol Natural products 0.000 title claims abstract description 30
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000013543 active substance Substances 0.000 claims abstract description 23
- 239000011159 matrix material Substances 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000010410 layer Substances 0.000 claims abstract description 15
- 239000011241 protective layer Substances 0.000 claims abstract description 4
- 239000013078 crystal Substances 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 description 15
- 229960003851 estradiol hemihydrate Drugs 0.000 description 7
- ZVVGLAMWAQMPDR-WVEWYJOQSA-N (8r,9s,13s,14s,17s)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;hydrate Chemical compound O.OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1.OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 ZVVGLAMWAQMPDR-WVEWYJOQSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- ROGIWVXWXZRRMZ-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1 ROGIWVXWXZRRMZ-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920004939 Cariflex™ Polymers 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- SXSRIEOCZKNURK-WAJSLEGFSA-N OCC(O)CO.[C@@H]12CCC(O)[C@@]1(C)CC[C@@H]1C3=C(CC[C@@H]21)C=C(O)C=C3 Chemical compound OCC(O)CO.[C@@H]12CCC(O)[C@@]1(C)CC[C@@H]1C3=C(CC[C@@H]21)C=C(O)C=C3 SXSRIEOCZKNURK-WAJSLEGFSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 150000003950 cyclic amides Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- -1 glycerine ester Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000003230 hygroscopic agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4429667A DE4429667C2 (de) | 1994-08-20 | 1994-08-20 | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
| PCT/EP1995/003201 WO1996005814A1 (de) | 1994-08-20 | 1995-08-12 | Estradiol-tts mit wasserbindenden zusätzen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO970360D0 NO970360D0 (no) | 1997-01-28 |
| NO970360L NO970360L (no) | 1997-01-28 |
| NO313984B1 true NO313984B1 (no) | 2003-01-13 |
Family
ID=6526231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19970360A NO313984B1 (no) | 1994-08-20 | 1997-01-28 | Östradioltransdermalt terapeutisk system |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5902602A (hu) |
| EP (1) | EP0776199B1 (hu) |
| JP (1) | JP3825799B2 (hu) |
| KR (1) | KR100401136B1 (hu) |
| CN (1) | CN1078461C (hu) |
| AT (1) | ATE185067T1 (hu) |
| AU (1) | AU695970B2 (hu) |
| CZ (1) | CZ289397B6 (hu) |
| DE (2) | DE4429667C2 (hu) |
| DK (1) | DK0776199T3 (hu) |
| ES (1) | ES2139932T3 (hu) |
| FI (1) | FI118720B (hu) |
| GR (1) | GR3032218T3 (hu) |
| HU (1) | HU226959B1 (hu) |
| IL (1) | IL114949A (hu) |
| MX (1) | MX9701302A (hu) |
| NO (1) | NO313984B1 (hu) |
| NZ (1) | NZ291813A (hu) |
| PL (1) | PL180965B1 (hu) |
| SK (1) | SK281626B6 (hu) |
| WO (1) | WO1996005814A1 (hu) |
| ZA (1) | ZA956925B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698217A (en) * | 1995-05-31 | 1997-12-16 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device containing a desiccant |
| DE19600347A1 (de) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus |
| DE19713141A1 (de) * | 1996-03-29 | 1997-10-30 | Labtec Gmbh | Transdermales System mit Melatonin |
| DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| US10493049B2 (en) | 2016-02-10 | 2019-12-03 | Niracle LLC | Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations |
| EP4308088A4 (en) | 2021-11-08 | 2024-06-12 | Weiyong Li | TRANSDERMAL DRUG DELIVERY SYSTEM FOR DELIVERING DRUG TO A PATIENT |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE12731T1 (de) * | 1979-01-11 | 1985-05-15 | Key Pharma | Polymere diffusionsmatrix und verfahren zu deren herstellung. |
| US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
| CA1163559A (en) * | 1980-07-09 | 1984-03-13 | Alec D. Keith | Polymeric diffusion matrix for administration of drugs |
| DE3333240A1 (de) * | 1983-09-12 | 1985-03-28 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur transdermalen applikation von arzneimittelwirkstoffen |
| ZA853488B (en) * | 1984-05-10 | 1986-12-30 | American Home Prod | Transdermal dosage form |
| US4810499A (en) * | 1984-10-01 | 1989-03-07 | Biotek, Inc. | Transdermal drug delivery system and method |
| US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
| US4788062A (en) * | 1987-02-26 | 1988-11-29 | Alza Corporation | Transdermal administration of progesterone, estradiol esters, and mixtures thereof |
| US4764379A (en) * | 1987-08-24 | 1988-08-16 | Alza Corporation | Transdermal drug delivery device with dual permeation enhancers |
| US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
| US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
| DD279818A1 (de) * | 1989-02-06 | 1990-06-20 | Jenapharm Veb | Verfahren zur herstellung eines medizinischen pflasters |
| DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
| AR246186A1 (es) * | 1989-11-17 | 1994-07-29 | Beta Pharm Co | Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. |
| DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
| US5518734A (en) * | 1991-09-25 | 1996-05-21 | Beta Pharmaceuticals Co. | Transdermal delivery system for estradiol and process for manufacturing said device |
| DE4210711A1 (de) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
| ATE184473T1 (de) * | 1992-06-11 | 1999-10-15 | Theratech Inc | Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung |
| DE59409873D1 (de) * | 1993-04-20 | 2001-10-25 | Hexal Ag | Wirkstoffpflaster |
-
1994
- 1994-08-20 DE DE4429667A patent/DE4429667C2/de not_active Expired - Fee Related
-
1995
- 1995-08-12 CZ CZ1997509A patent/CZ289397B6/cs not_active IP Right Cessation
- 1995-08-12 PL PL95319013A patent/PL180965B1/pl not_active IP Right Cessation
- 1995-08-12 DE DE59506962T patent/DE59506962D1/de not_active Expired - Lifetime
- 1995-08-12 NZ NZ291813A patent/NZ291813A/en not_active IP Right Cessation
- 1995-08-12 CN CN95194677A patent/CN1078461C/zh not_active Expired - Fee Related
- 1995-08-12 EP EP95929856A patent/EP0776199B1/de not_active Expired - Lifetime
- 1995-08-12 JP JP50775496A patent/JP3825799B2/ja not_active Expired - Lifetime
- 1995-08-12 WO PCT/EP1995/003201 patent/WO1996005814A1/de active IP Right Grant
- 1995-08-12 ES ES95929856T patent/ES2139932T3/es not_active Expired - Lifetime
- 1995-08-12 HU HU9701729A patent/HU226959B1/hu not_active IP Right Cessation
- 1995-08-12 SK SK220-97A patent/SK281626B6/sk not_active IP Right Cessation
- 1995-08-12 US US08/632,490 patent/US5902602A/en not_active Expired - Lifetime
- 1995-08-12 AU AU33449/95A patent/AU695970B2/en not_active Ceased
- 1995-08-12 MX MX9701302A patent/MX9701302A/es unknown
- 1995-08-12 KR KR1019970701108A patent/KR100401136B1/ko not_active IP Right Cessation
- 1995-08-12 DK DK95929856T patent/DK0776199T3/da active
- 1995-08-12 AT AT95929856T patent/ATE185067T1/de active
- 1995-08-15 IL IL11494995A patent/IL114949A/en not_active IP Right Cessation
- 1995-08-18 ZA ZA956925A patent/ZA956925B/xx unknown
-
1997
- 1997-01-28 NO NO19970360A patent/NO313984B1/no not_active IP Right Cessation
- 1997-02-19 FI FI970701A patent/FI118720B/fi not_active IP Right Cessation
-
1999
- 1999-12-22 GR GR990403305T patent/GR3032218T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO309891B1 (no) | Transdermalt terapeutisk system og fremgangsmÕte for fremstilling derav | |
| US7175853B1 (en) | Therapeutic system which can be moisture-activated | |
| KR101727347B1 (ko) | 디클로페낙 나트륨 함유 수성 패치 | |
| HUT73441A (en) | Transdermal therapeutic compositions and process for producing them | |
| JP2015503541A (ja) | 自発的に結晶化する傾向が低い経皮治療システム | |
| JP3227577B2 (ja) | 活性物質，１７−β−エストラジオール（無水）を含有する経皮医療システム | |
| CZ75797A3 (en) | Transdermal therapeutic system having the form of an adhesive plaster | |
| CA2407854C (en) | Occlusive transdermal therapeutic system with a non-occlusive backing layer | |
| NO313984B1 (no) | Östradioltransdermalt terapeutisk system | |
| AU723018B2 (en) | Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition | |
| KR100374476B1 (ko) | 친수성첨가제를함유하는에스트라디올함유트랜스더멀치료시스템 | |
| NO312878B1 (no) | Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater | |
| US5827245A (en) | Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous) | |
| CA2197867C (en) | Oestradiol transdermal therapeutic system comprising hygroscopic additives | |
| MXPA97001301A (en) | Transdermal therapeutic system containing estradiol comprising additives higrofili | |
| JPH06157297A (ja) | 医薬部材 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |